Ercem Atillasoy - Oct 20, 2022 Form 4/A - Amendment Insider Report for Allovir, Inc. (ALVR)

Role
Officer
Signature
/s/ Brett Hagen, as Attorney-in-Fact
Stock symbol
ALVR
Transactions as of
Oct 20, 2022
Transactions value $
-$18,272
Form type
4/A - Amendment
Date filed
10/26/2022, 04:15 PM
Date Of Original Report
Oct 24, 2022
Previous filing
Oct 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALVR Common Stock Sale -$5.32K -568 -0.43% $9.36 133K Oct 20, 2022 Direct F1, F2
transaction ALVR Common Stock Sale -$13K -1.53K -1.15% $8.48 131K Oct 21, 2022 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units, and does not represent a discretionary trade by the Reporting Person.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.08 to $9.72. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.40 to $8.61. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Remarks:

This Form 4/A is being filed correct the transaction dates reported in the original Form 4 filed on October 24, 2022. Officer Title: Chief Regulatory and Safety Officer